Rezolute Inc (RZLT)

5.24 +0.09 (+1.75%) USD  |  NASDAQ  |  Jan 03, 16:00
5.48 +0.24 (+4.58%) After-Hours: 20:00
More

Rezolute Research and Development Expense (Annual): 55.74M for June 30, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for RZLT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Janux Therapeutics Inc 54.92M
Cytokinetics Inc --
TransMedics Group Inc 63.27M
NovaBay Pharmaceuticals Inc 0.068M
Palatin Technologies Inc 22.40M